Our present study showed for the first time that, CXCL1 is over-expressed in AD patients’ monocytes, which contributes to Aβ-induced transendothelial migration of monocytes through the interaction with CXCR2 in HBMEC. This evidence concerns the gene CXCR2 and Alzheimer disease.